FAKTOR-OPTIONSSCHEIN - MERCK & CO. Share Price

Certificat

DE000MG13713

Real-time Bid/Ask 16:45:52 26/06/2024 BST
6.06 EUR / 6.07 EUR -0.74% Intraday chart for FAKTOR-OPTIONSSCHEIN - MERCK & CO.
Current month-27.35%
1 month-15.96%
Date Price Change
26/06/24 6.02 -1.47%
25/06/24 6.11 +1.33%
24/06/24 6.03 -10.80%
21/06/24 6.76 -1.60%
20/06/24 6.87 -7.29%

Delayed Quote Börse Stuttgart

Last update June 26, 2024 at 04:35 pm

More quotes

Static data

Product typeProductos Exóticos
Buy / SellCALL
Underlying MERCK & CO., INC.
Issuer Morgan Stanley
WKN MG1371
ISINDE000MG13713
Date issued 26/03/2024
Strike 159.5 $
Maturity Unlimited
Parity 4.09 : 1
Emission price 10
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 9.3
Lowest since issue 5.97
Spread 0.01
Spread %0.16%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
132.9 USD
Average target price
142.7 USD
Spread / Average Target
+7.34%
Consensus